ResearcherCapital Medical UniversityActive in the last 2 years
Yingying Tong
Matched on ORCID iD 0000-0001-8542-5216; OpenAlex author ID A5082816482. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2023: 1 paper · 2024: 1 paper · 2025: 2 papers
Papers 4
- Identification of Metabolic Characteristic-Pancreatic Ductal Adenocarcinoma Associations Using Mendelian Randomization and Metabolomics. Co-author DOI 10.1007/s12029-025-01173-4↗
- The glycolytic enzyme PGK1 phosphorylates MORC2 to Confer radioresistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41419-025-08177-9↗
- Hexokinase 2 nonmetabolic function-mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progression. Co-author DOI 10.1111/cas.16204↗
- Integrative Analysis of PAIP2B to Identify a Novel Biomarker for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1055/s-0043-1777789↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- yaoxian Xiang · 4 shared papers, 2023–2025 · strength 0.89
- Paper Identification of Metabolic Characteristic-Pancreatic Ductal Adenocarcinoma Associations Using Mendelian Randomization … DOI 10.1007/s12029-025-01173-4↗
- Paper The glycolytic enzyme PGK1 phosphorylates MORC2 to Confer radioresistance in pancreatic ductal adenocarcinoma. DOI 10.1038/s41419-025-08177-9↗
- Paper Hexokinase 2 nonmetabolic function-mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progressi… DOI 10.1111/cas.16204↗
- Jing Wang · 3 shared papers, 2023–2025 · strength 0.63
- Paper The glycolytic enzyme PGK1 phosphorylates MORC2 to Confer radioresistance in pancreatic ductal adenocarcinoma. DOI 10.1038/s41419-025-08177-9↗
- Paper Hexokinase 2 nonmetabolic function-mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progressi… DOI 10.1111/cas.16204↗
- Paper Integrative Analysis of PAIP2B to Identify a Novel Biomarker for Pancreatic Ductal Adenocarcinoma. DOI 10.1055/s-0043-1777789↗
- Li Wang · 2 shared papers, 2024–2025 · strength 0.43
- Dong Yan · 2 shared papers, 2024–2025 · strength 0.43
- Jing Wang · 1 shared paper, 2025 · strength 0.27
- Yan Dong · 1 shared paper, 2025 · strength 0.27
- Lijun Yang · 1 shared paper, 2025 · strength 0.22
- Li Wang · 1 shared paper, 2023 · strength 0.19
- Yan Dong · 1 shared paper, 2023 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.